washingtonpost.com: MedImmune's Pain-Free Ambitions

MedImmune's Pain-Free Ambitions
If Approved by the FDA, FluMist Would Become First Vaccine Delivered as a Nasal Spray

By Terence Chea
Washington Post Staff Writer
Monday, March 18, 2002; Page E01